Login / Signup

Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial.

Maurizio FavaStephen M StahlLuca PaniSara De MartinAndrew J CutlerVladimir MaleticCharles W GorodetzkyFrank J VocciFrank L SapienzaThomas R KostenCornelia KrögerPaggard ChampasaCedric O'GormanClotilde GuidettiAndrea AlimontiStefano ComaiAndrea MattareiFranco FolliDavid BushnellSergio TraversaCharles E InturrisiPaolo L ManfrediMarco Pappagallo
Published in: The Journal of clinical psychiatry (2024)
Trial Registration: ClinicalTrials.gov identifier: NCT04688164.
Keyphrases
  • major depressive disorder
  • study protocol
  • randomized controlled trial
  • bipolar disorder
  • phase iii
  • clinical trial
  • phase ii
  • double blind